Skip to main content
PMC home page
Gut logoLink to Gut
. 1995 Oct;37(4):580–584. doi: 10.1136/gut.37.4.580

Fetal mortality associated with cholestasis of pregnancy and the potential benefit of therapy with ursodeoxycholic acid.

M H Davies 1, R C da Silva 1, S R Jones 1, J B Weaver 1, E Elias 1
PMCID: PMC1382915  PMID: 7489950

Abstract

Cholestasis of pregnancy is associated with increased fetal morbidity and mortality and should be treated actively. The significance attached to pruritus in pregnancy is often minimal, but it is a cardinal symptom of cholestasis of pregnancy, which may have no other clinical features. Eight women with previous cholestasis of pregnancy were referred to The Liver Unit within a 12 month period for advice concerning future pregnancies. Thirteen pregnancies had been affected by cholestasis of pregnancy and 12 had been treated expectantly with resultant perinatal morbidity or mortality in 11 (one normal delivery), including; eight stillbirths, two premature deliveries with fetal distress (one died in perinatal period), and an emergency caesarean section for fetal distress. The other pregnancy was treated actively and delivery was uncomplicated. Subsequently, three of these cases with recurrent cholestasis of pregnancy were referred while pregnant. In each, cholestasis developed with severe pruritus, gross increase of serum bile acids, and deranged liver tests. Each was treated with the choleretic agent ursodeoxycholic acid, with rapid clinical improvement and resolution of deranged biochemistry. In conclusion, cholestasis of pregnancy continues to be treated expectantly despite its association with increased morbidity and mortality and evidence suggesting improved prognosis with active treatment and the potential of reducing the associated perinatal mortality. In an uncontrolled series of three patients with cholestasis of pregnancy, ursodeoxycholic acid seemed to provide safe and effective therapy.

Full text

PDF
580

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berg B., Helm G., Petersohn L., Tryding N. Cholestasis of pregnancy. Clinical and laboratory studies. Acta Obstet Gynecol Scand. 1986;65(2):107–113. doi: 10.3109/00016348609158363. [DOI] [PubMed] [Google Scholar]
  2. Boelsterli U. A., Rakhit G., Balazs T. Modulation by S-adenosyl-L-methionine of hepatic Na+,K+-ATPase, membrane fluidity, and bile flow in rats with ethinyl estradiol-induced cholestasis. Hepatology. 1983 Jan-Feb;3(1):12–17. doi: 10.1002/hep.1840030102. [DOI] [PubMed] [Google Scholar]
  3. Davidson C. S. Hepatic disease and pregnancy. J Reprod Med. 1973 Mar;10(3):107–110. [PubMed] [Google Scholar]
  4. Fisk N. M., Bye W. B., Storey G. N. Maternal features of obstetric cholestasis: 20 years experience at King George V Hospital. Aust N Z J Obstet Gynaecol. 1988 Aug;28(3):172–176. doi: 10.1111/j.1479-828x.1988.tb01657.x. [DOI] [PubMed] [Google Scholar]
  5. Fisk N. M., Storey G. N. Fetal outcome in obstetric cholestasis. Br J Obstet Gynaecol. 1988 Nov;95(11):1137–1143. doi: 10.1111/j.1471-0528.1988.tb06791.x. [DOI] [PubMed] [Google Scholar]
  6. Frezza M., Pozzato G., Chiesa L., Stramentinoli G., di Padova C. Reversal of intrahepatic cholestasis of pregnancy in women after high dose S-adenosyl-L-methionine administration. Hepatology. 1984 Mar-Apr;4(2):274–278. doi: 10.1002/hep.1840040217. [DOI] [PubMed] [Google Scholar]
  7. Friedlaender P., Osler M. Icterus and pregnancy. Am J Obstet Gynecol. 1967 Apr 1;97(7):894–900. doi: 10.1016/0002-9378(67)90513-3. [DOI] [PubMed] [Google Scholar]
  8. Garoff L. Prediction of fetal outcome by urinary estriol, maternal serum placental lactogen, and alpha-fetoprotein in diabetes and hepatosis of pregnancy. Obstet Gynecol. 1976 Dec;48(6):659–666. [PubMed] [Google Scholar]
  9. Gonzalez M. C., Iglesias J., Tiribelli C., Ribalta J., Reyes H., Hernandez I., Bianchi M., Andrighetti F., Molina C. Epomediol ameliorates pruritus in patients with intrahepatic cholestasis of pregnancy. J Hepatol. 1992 Sep;16(1-2):241–242. doi: 10.1016/s0168-8278(05)80122-9. [DOI] [PubMed] [Google Scholar]
  10. Heikkinen J., Mäentausta O., Ylöstalo P., Jänne O. Changes in serum bile acid concentrations during normal pregnancy, in patients with intrahepatic cholestasis of pregnancy and in pregnant women with itching. Br J Obstet Gynaecol. 1981 Mar;88(3):240–245. [PubMed] [Google Scholar]
  11. Hirvioja M. L., Tuimala R., Vuori J. The treatment of intrahepatic cholestasis of pregnancy by dexamethasone. Br J Obstet Gynaecol. 1992 Feb;99(2):109–111. doi: 10.1111/j.1471-0528.1992.tb14465.x. [DOI] [PubMed] [Google Scholar]
  12. Johnston W. G., Baskett T. F. Obstetric cholestasis. A 14 year review. Am J Obstet Gynecol. 1979 Feb 1;133(3):299–301. doi: 10.1016/0002-9378(79)90683-5. [DOI] [PubMed] [Google Scholar]
  13. Laatikainen T., Ikonen E. Fetal prognosis in obstetric hepatosis. Ann Chir Gynaecol Fenn. 1975;64(3):155–164. [PubMed] [Google Scholar]
  14. Laatikainen T., Ikonen E. Serum bile acids in cholestasis of pregnancy. Obstet Gynecol. 1977 Sep;50(3):313–318. [PubMed] [Google Scholar]
  15. Laatikainen T., Tulenheimo A. Maternal serum bile acid levels and fetal distress in cholestasis of pregnancy. Int J Gynaecol Obstet. 1984 Apr;22(2):91–94. doi: 10.1016/0020-7292(84)90019-5. [DOI] [PubMed] [Google Scholar]
  16. Leuschner U., Fischer H., Kurtz W., Güldütuna S., Hübner K., Hellstern A., Gatzen M., Leuschner M. Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial. Gastroenterology. 1989 Nov;97(5):1268–1274. doi: 10.1016/0016-5085(89)91698-3. [DOI] [PubMed] [Google Scholar]
  17. Lunzer M., Barnes P., Byth K., O'Halloran M. Serum bile acid concentrations during pregnancy and their relationship to obstetric cholestasis. Gastroenterology. 1986 Oct;91(4):825–829. doi: 10.1016/0016-5085(86)90682-7. [DOI] [PubMed] [Google Scholar]
  18. Mazzella G., Rizzo N., Salzetta A., Iampieri R., Bovicelli L., Roda E. Management of intrahepatic cholestasis in pregnancy. Lancet. 1991 Dec 21;338(8782-8783):1594–1595. doi: 10.1016/0140-6736(91)92415-x. [DOI] [PubMed] [Google Scholar]
  19. ORELLANA J. M., GONZALEZ RODRIGUEZ A., AGUIRRE E. [Benign jaundice of pregnancy. (Intrahepatic cholestasis of pregnancy)]. Rev Med Chil. 1961 Sep;89:676–679. [PubMed] [Google Scholar]
  20. Palma J., Reyes H., Ribalta J., Iglesias J., Gonzalez M. C., Hernandez I., Alvarez C., Molina C., Danitz A. M. Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy. Hepatology. 1992 Jun;15(6):1043–1047. doi: 10.1002/hep.1840150612. [DOI] [PubMed] [Google Scholar]
  21. Poupon R. E., Eschwège E., Poupon R. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. Interim analysis of a double-blind multicentre randomized trial. The UDCA-PBC Study Group. J Hepatol. 1990 Jul;11(1):16–21. doi: 10.1016/0168-8278(90)90265-s. [DOI] [PubMed] [Google Scholar]
  22. Reid R., Ivey K. J., Rencoret R. H., Storey B. Fetal complications of obstetric cholestasis. Br Med J. 1976 Apr 10;1(6014):870–872. doi: 10.1136/bmj.1.6014.870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Rencoret R., Aste H. Jaundice during pregnancy. Med J Aust. 1973 Jan 27;1(4):167–169. doi: 10.5694/j.1326-5377.1973.tb119698.x. [DOI] [PubMed] [Google Scholar]
  24. Ribalta J., Reyes H., Gonzalez M. C., Iglesias J., Arrese M., Poniachik J., Molina C., Segovia N. S-adenosyl-L-methionine in the treatment of patients with intrahepatic cholestasis of pregnancy: a randomized, double-blind, placebo-controlled study with negative results. Hepatology. 1991 Jun;13(6):1084–1089. [PubMed] [Google Scholar]
  25. Roncaglia N., Trio D., Roffi L., Ciarla I., Tampieri A., Scian A., Bottino S. Colestasi intraepatica gravidica: incidenza, decorso, complicanze. Ann Ostet Ginecol Med Perinat. 1991 May-Jun;112(3):146–151. [PubMed] [Google Scholar]
  26. Roszkowski I., Pisarek-Miedzińska D. Jaundice in pregnancy. II. Clinical course of pregnancy and delivery and condition of neonate. Am J Obstet Gynecol. 1968 Jun 15;101(4):500–503. [PubMed] [Google Scholar]
  27. Shaw D., Frohlich J., Wittmann B. A., Willms M. A prospective study of 18 patients with cholestasis of pregnancy. Am J Obstet Gynecol. 1982 Mar 15;142(6 Pt 1):621–625. doi: 10.1016/s0002-9378(16)32430-9. [DOI] [PubMed] [Google Scholar]
  28. Stramentinoli G., Di Padova C., Gualano M., Rovagnati P., Galli-Kienle M. Ethynylestradiol-induced impairment of bile secretion in the rat: protective effects of S-adenosyl-L-methionine and its implication in estrogen metabolism. Gastroenterology. 1981 Jan;80(1):154–158. [PubMed] [Google Scholar]
  29. Wilson B. R., Haverkamp A. D. Cholestatic jaundice of pregnancy: new perspectives. Obstet Gynecol. 1979 Nov;54(5):650–652. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES